{"id":39191,"date":"2026-04-16T00:46:16","date_gmt":"2026-04-16T00:46:16","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=39191"},"modified":"2026-04-16T00:53:37","modified_gmt":"2026-04-16T00:53:37","slug":"neusoft-medical-launches-worlds-first-pediatric-dedicated-pet-ct-with-170ps-tof-resolution","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/neusoft-medical-launches-worlds-first-pediatric-dedicated-pet-ct-with-170ps-tof-resolution\/","title":{"rendered":"Neusoft Medical Launches World’s First Pediatric Dedicated PET\/CT with 170ps TOF Resolution"},"content":{"rendered":"\n

At the 93rd China International Medical Equipment Fair (CMEF), Neusoft Medical<\/a> unveiled the NeuEdge: the world\u2019s first paediatric-dedicated, fully digital PET\/CT system with 170 ps-level time-of-flight (TOF) resolution. As a flagship product, NeuEdge embodies over a decade of Neusoft Medical\u2019s expertise in molecular imaging and its comprehensive independent R&D capabilities. Achieving breakthrough performance enhancements across multiple core technologies fills a global void in ultra-high-end paediatric PET\/CT, offering a brand-new solution for low-dose, high-speed scanning, high-definition tumour imaging, and precision diagnosis and treatment in children. This launch also represents a significant milestone for Chinese-made high-end nuclear medicine equipment on the global stage.<\/p>\n\n\n\n

The NeuEdge PET\/CT represents Neusoft Medical’s core product in its ultra-high-end medical imaging portfolio. Built on fully independent R&D, the system redefines the technical standards for pediatric PET\/CT through innovations in imaging precision, core components, and intelligent technologies. Regarding time resolution, the NeuEdge achieves a TOF resolution of 170ps, which is a globally advanced level that fundamentally resets the standards for PET\/CT imaging accuracy and efficiency, providing a critical foundation for precise pediatric diagnosis. In terms of core components, Neusoft Medical has developed a proprietary 64-channel high-integration ASIC 2.0 chip, which combines low power consumption, a compact footprint, and high performance. Paired with a dedicated water-cooling system, it reduces detector thermal drift by 90% and supports 200 cm axial expansion without joints, achieving 100% self-sufficiency in core components. For image clarity, the system features a 1024\u00d71024 dual-wide matrix, delivering a visible resolution of 0.6 mm to capture tiny lesions with exceptional definition, significantly reducing the risks of misdiagnosis and missed diagnosis. Furthermore, the NeuEdge integrates a full-field AI nuclear medicine platform with AI-TRIO deep learning reconstruction technology. Leveraging the advantages of 170ps TOF, the system improves the signal-to-noise ratio by 7.6 times, enables a total-body scan in just 60 seconds, and reduces the radiotracer dose to as low as 0.03 mCi\/kg \u2014 balancing diagnostic efficiency with maximum safety for pediatric patients.<\/p>\n\n\n\n

The NeuEdge PET\/CT system is tailored to the unique needs of pediatric patients, offering specialized solutions for oncology, neurology, cardiology, pulmonology, and dynamic imaging. With its core advantages of “clearer imaging, faster scanning, and lower dosage,” the system enables the early detection, diagnosis, and treatment of pediatric tumors, thereby reducing the burden on young patients and their families. From its self-developed core technologies and enhanced system performance to its optimized clinical workflows and improved patient experiences, the NeuEdge PET\/CT provides a comprehensive clinical solution that is highly efficient, precise, and uses a low dose.<\/p>\n","protected":false},"excerpt":{"rendered":"

Designed to address critical clinical needs, such as low radiation dose, rapid scanning, and high-definition imaging for children, NeuEdge PET\/CT system fills a global gap in ultra-high-end pediatric nuclear medicine, positioning Chinese-made advanced equipment at the forefront of the international market.<\/p>\n","protected":false},"author":2,"featured_media":39192,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[5,488,676,25],"tags":[453,627,787],"class_list":["post-39191","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asia-pacific","category-breaking-news","category-imaging-diagnostics","category-products-technologies","tag-china","tag-cmef","tag-pet-ct"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/39191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=39191"}],"version-history":[{"count":6,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/39191\/revisions"}],"predecessor-version":[{"id":39198,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/39191\/revisions\/39198"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/39192"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=39191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=39191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=39191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}